Treating metastatic melanoma with Stereotactic ABlative Radiotherapy and IMmune Pathway ACTivation: A phase 1 dose-escalation trial

  • Yu, Di (Primary Chief Investigator (PCI))

Project: Research

StatusFinished
Effective start/end date3/05/163/05/17